University of Maryland BioPark, Life Sciences Conference Center
Meet with Bahija Jallal, Ph.D., Executive Vice President of Research and Development, MedImmune The Changing Face of the Biopharmaceutical Industry—Creating a Culture of Innovation
The biopharmaceutical industry is not the same as it was even a decade ago. Today, there are even more pressures to produce not just safe and effective drugs but safe and effective drugs that the payers are willing to pay for. We also know that research and development costs are increasing while R&D productivity continues to be on the decline. How can we continue to make it in the industry when our ultimate goal is to provide much needed drugs to patients with unmet medical needs?